- Home
- CELC vs SA Comparison
CELC vs SA Comparison
Compare CELC & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | SA |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CELC | SA |
|---|---|---|
| Price | $114.28 | $31.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $106.63 | $65.00 |
| AVG Volume (30 Days) | 527.9K | ★ 763.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.58 | $9.40 |
| 52 Week High | $120.32 | $40.06 |
Technical Indicators
Market Signals| Indicator | CELC | SA |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 41.03 |
| Support Level | $97.75 | $28.46 |
| Resistance Level | $114.54 | $40.06 |
| Average True Range (ATR) | 5.14 | 1.89 |
| MACD | 0.36 | -0.65 |
| Stochastic Oscillator | 63.53 | 8.88 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.